Gilead Sciences Inc (GILD) Common Stock USD0.001
Share news, reports & tips
11 January 2021 13:46
(Sharecast News) - Gilead Sciences has upped its full-year profit guidance following strong sales of its Covid-19 treatment remdesivir.
20 November 2020 14:26
(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead...
20 November 2020 12:35
(Sharecast News) - WHO advises doctors against treating Covid-19 patients with Gilead Science's remdesivir drug (under the name Veklury) that has "no meaningful effect" on survival or need for...
27 October 2020 14:28
(Sharecast News) - Eli Lilly and researchers at the National Institutes of Health have paused a late-stage clinical trial into a combination of the company's antibody treatment against Covid-19 in...
23 October 2020 11:28
(Sharecast News) - Gilead Sciences's antiviral Veklury, better known as Remdesivir, was given the stamp of the approval by the country's health watchdog overnight for use as a treatment against...
10 July 2020 14:09
(Sharecast News) - Gilead Sciences's Remdesivir antiviral treatment for the novel coronavirus may cut the risk of death by nearly two-thirds.
29 June 2020 12:00
(Sharecast News) - Gilead Sciences has announced it will charge developed countries $390 a vial for remdesivir, its antiviral drug currently being investigated for use in Covid-19 patients.
22 June 2020 18:32
(Sharecast News) - US biotechnology giant Gilead Sciences will start testing an inhaled version of its treatment for Covid-19, Remdesivir, in August.
8 June 2020 14:43
(Sharecast News) - JP Morgan has reiterated its 'overweight' rating on AstraZeneca, following reports that the drugs manufacturer was mulling a possible merger with US rival Gilead Sciences.
8 June 2020 07:33
(Sharecast News) - AstraZeneca has approached Gilead Sciences of the US about a potential merger to create a $240bn drugmaker, according to a report.
7 June 2020 12:21
(Sharecast News) - Fresh evidence of China's shocking cover-up of the pandemic outbreak has been found in censored media reports from Wuhan. Samples taken from sick patients and analysed by at least...
7 May 2020 15:34
(Sharecast News) - Japanese health authorities have approved Gilead Sciences's Remdesivir anti-viral drug as a treatment for Covid-19.
Company announcements Announcements
No company announcements about Gilead Sciences Inc Common Stock USD0.001 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.